NCT04975516 - Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 18, 2023

Primary Completion Date

July 2, 2026

Study Completion Date

July 2, 2027

Conditions

Metastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8Recurrent Pancreatic AdenocarcinomaOligometastatic Pancreatic Ductal Adenocarcinoma

Interventions

DRUG

Chemotherapy

Given chemotherapy

RADIATION

Stereotactic Body Radiation Therapy

Undergo SBRT

PROCEDURE

Computed Tomography

Undergo CT

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Biospecimen Collection

Undergo blood collection

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

32224-9980

RECRUITING

Mayo Clinic in Florida, Jacksonville